Log In
person
Ultragenyx Pharmaceutical Inc
RARE
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Biotech Drug Design |
Patent Licensing to Drug Manufacturers
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
253.84M | 58.45% |
| Biotech Drug Design |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
180.41M | 41.55% |
| keyboard_arrow_down |
Biotech Drug Design
Patent Licensing to Drug Manufacturers
|
253.84M | 58.45% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Biotech Drug Design
Branded Pharmaceuticals (outsourced)
|
180.41M | 41.55% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||